Stock News

These 3 Major Drug Manufacturers Are Strong Performers
Stocks rebound as investors eye trade headlines
Merck to Buy Peloton for Up to $2.2 Billion, Day Before IPO
Merck to Acquire Peloton Therapeutics for About $1B in Cash
Merck to acquire Peloton Therapeutics for upfront payment of $1.05 billion in cash
Merck to Acquire Peloton Therapeutics, Bolstering Oncology Pipeline
Stocks making the biggest moves after hours: GM, Snap, Merck and more
Merck's Keytruda fails as monotherapy in breast cancer study
Merck shares slip as Keytruda fails another clinical trial
Merck Provides Update on Phase 3 KEYNOTE-119 Study of KEYTRUDA® (pembrolizumab) Monotherapy in Previously-Treated Patients with Metastatic Triple-Negative Breast Cancer
U.S. Supreme Court gives Merck another shot to avoid Fosamax lawsuits
CPPIB buys partial Keytruda royalty interest from British charity LifeArc

As seen on...